Lebermetastasen: Studien-(Updates) von APPROACH bis VOLFI
Prim. Univ.-Prof. Dr. Thomas Grünberger, Chirurgische Abteilung, Sozialmedizinisches Zentrum Süd – Kaiser-Franz-Josef-Spital mit Gottfried von Preyer’schem Kinderspital, fasst die neuen Daten zur Therapie von Lebermetastasen zusammen.
Behandelte Abstracts in diesem Video:
Chun YJ et al., A randomized phase II study of perioperative chemotherapy plus bevacizumab versus postoperative chemotherapy plus bevacizumab inpatients with upfront resectable hepatic colorectal metastases (APPROACH). Abstract 3528
https://meetinglibrary.asco.org/record/158826/abstract
Pugh SA et al., Surgical quality and the impact of liver resection on outcome in the New EPOC study. Abstract 3559
https://meetinglibrary.asco.org/record/158935/abstract
Caballero CA et al., EORTC-ESSO 1409 GITCG: A prospective colorectal liver metastasis database with an integrated quality assurance program (CLIMB). Abstract 3558
https://meetinglibrary.asco.org/record/158821/abstract
Geissler M et al., mFOLFOXIRI + panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): A randomized phase II VOLFI trial of the AIO (AIO- KRK0109).Abstract 3509
https://meetinglibrary.asco.org/record/158746/abstract
ASCO Annual Meeting 2018